What is NDC 72482-100?

72482-100 is the product NDC for Vonjo (pacritinib), Pacritinib 100 mg/1 capsule, listed with the FDA by Sobi, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Sobi, Inc., NDC labeler code 72482. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Vonjo?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Vonjo NDC 72482-100 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72482-100Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72482-0100Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72482-100-12	72482010012	40 CARTON in 1 BOX (72482-100-12) / 1 BOTTLE in 1 CARTON / 120 CAPSULE in 1 BOTTLEMarketed from Feb 28, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vonjo
Generic name (nonproprietary): pacritinib
Active ingredients: Pacritinib — 100 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Sobi, Inc.NDC labeler code 72482
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 208712
Marketing start: Feb 28, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Breast Cancer Resistance Protein Inhibitors (Mechanism)Cytochrome P450 1A2 Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Janus Kinase Inhibitors (Mechanism)Organic Cation Transporter 1 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)Tyrosine Kinase Inhibitors (Mechanism)
Identifiers: Product ID 72482-100_eaca3a36-2256-47c8-ae49-3a866c61a133SPL ID eaca3a36-2256-47c8-ae49-3a866c61a133SPL set ID 4b5ab444-0e1a-4984-99db-76ad11a298eeRxCUI 2595248, 2595254UNII G22N65IL3O
Pharmacologic class: Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472482010012 followed by a unit qualifier and the quantity

Package 72482-0100-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 30, 2026.

Indications (excerpt from the label)

VONJO is indicated for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF) with a platelet count below 50 × 10 9 /L. This indication is approved under accelerated approval based on spleen volume reduction [see Clinical Studies ( 14 )] . Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s). VONJO is a kinase inhibitor indicated for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72482-100

What is NDC 72482-100?: 72482-100 is the product NDC for Vonjo (pacritinib), Pacritinib 100 mg/1 capsule, listed with the FDA by Sobi, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Vonjo (Pacritinib).
What is the active ingredient?: Pacritinib.
Who is the labeler?: Sobi, Inc., NDC labeler code 72482. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vonjo?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Vonjo (Pacritinib) NDC 72482-100